Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
Authors
Keywords
-
Journal
Future Oncology
Volume 8, Issue 4, Pages 451-462
Publisher
Future Medicine Ltd
Online
2012-04-19
DOI
10.2217/fon.12.25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histology- and gender-related associations of ERCC1, RRM1, and TS biomarkers in 1,802 patients with NSCLC: Implications for therapy.
- (2017) D. R. Gandara et al. JOURNAL OF CLINICAL ONCOLOGY
- The effect of CYP2C19 polymorphism on the tolerability of ARQ 197: Results from phase I trial in Japanese patients with metastatic solid tumors.
- (2017) T. Nishina et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).
- (2017) M. G. Kris et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial
- (2011) Tony SK MOK et al. Asia-Pacific Journal of Clinical Oncology
- Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Ethnic Difference in Hematological Toxicity in Patients with Non-small Cell Lung Cancer Treated with Chemotherapy: A Pooled Analysis on Asian versus Non-Asian in Phase II and III Clinical Trials
- (2011) Yoshikazu Hasegawa et al. Journal of Thoracic Oncology
- Ethnic Differences in Survival Outcome in Patients with Advanced Stage Non-small Cell Lung Cancer: Results of a Meta-Analysis of Randomized Controlled Trials
- (2011) Ross A. Soo et al. Journal of Thoracic Oncology
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
- (2011) Chenguang Li et al. PLoS One
- Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program
- (2011) Karynsa Cetin et al. Clinical Epidemiology
- Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer1
- (2010) Primo N. Lara et al. CANCER
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer
- (2010) Ayesha S. Bryant et al. Journal of Thoracic Oncology
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
- (2010) Danny R. Youlden et al. Journal of Thoracic Oncology
- ALK Gene Rearrangements: A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung Cancer
- (2010) Benjamin Solomon et al. Journal of Thoracic Oncology
- Prognostic Factors for Survival in Extensive Stage Small Cell Lung Cancer (ED-SCLC): The Importance of Smoking History, Socioeconomic and Marital Statuses, and Ethnicity
- (2010) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking Status
- (2010) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Korean Ethnicity as Compared with White Ethnicity Is an Independent Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer before and after the Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Era
- (2010) Myung-Ju Ahn et al. Journal of Thoracic Oncology
- Japanese Ethnicity Compared with Caucasian Ethnicity and Never-Smoking Status Are Independent Favorable Prognostic Factors for Overall Survival in Non-small Cell Lung Cancer: A Collaborative Epidemiologic Study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry Databases
- (2010) Tomoya Kawaguchi et al. Journal of Thoracic Oncology
- Genetics of lung-cancer susceptibility
- (2010) Paul Brennan et al. LANCET ONCOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in cancer mortality in the elderly in Japan, 1970-2007
- (2009) L. Yang et al. ANNALS OF ONCOLOGY
- Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy
- (2009) P. H. O'Donnell et al. CLINICAL CANCER RESEARCH
- Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics
- (2009) David R. Gandara et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
- (2009) Kathy S. Albain et al. JNCI-Journal of the National Cancer Institute
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
- (2009) Robert Pirker et al. LANCET
- First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Ross A Soo et al. LANCET ONCOLOGY
- KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies
- (2009) Chen Mao et al. LUNG CANCER
- EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer
- (2009) Meina Wu et al. LUNG CANCER
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging ethnic differences in lung cancer therapy
- (2008) I Sekine et al. BRITISH JOURNAL OF CANCER
- Reversed mutation rates ofKRASandEGFRgenes in adenocarcinoma of the lung in Taiwan and their implications
- (2008) Chun-Chieh Wu et al. CANCER
- EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan
- (2008) Toshimi Takano et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started